Annabelle
Annabelle Andreau-Wiedenmaier, Aachen DE
Patent application number | Description | Published |
---|---|---|
20090323162 | ACTIVE DEVICE HAVING VARIABLE ENERGY/OPTICAL PROPERTIES - The invention relates to an active device having variable energy/light transmission properties ( | 12-31-2009 |
20100208325 | ELECTROACTIVE MATERIAL CONTAINING ORGANIC COMPOUNDS HAVING POSITIVE AND NEGATIVE REDOX ACTIVITIES RESPECTIVELY, PROCESS AND KIT FOR MANUFACTURING THIS MATERIAL, ELECTRICALLY CONTROLLABLE DEVICE AND GLAZING UNITS USING SUCH AN ELECTROACTIVE MATERIAL - This electroactive material comprises a self-supporting polymer matrix, inserted into which is an electroactive system comprising or constituted by: | 08-19-2010 |
20110187984 | METHOD FOR REGENERATING THE LIQUID CRYSTALS OF VARIABLE LIGHT-SCATTERING ELECTRICALLY CONTROLLED SYSTEMS, ELECTRICAL POWER SUPPLY AND DEVICE FOR SAID REGENERATION - A method for regenerating liquid crystals of a variable light-scattering electrically controlled system including a substrate carrying a liquid crystal element between two electrodes connected to an electrical power supply, the method including: supplying data for the regeneration comprising a regeneration duration DT and at least one regeneration setpoint C, programming for the regeneration comprising comparing operational data with the regeneration setpoint C, automatically regenerating by automatic power-down of the electrical circuit for the period of the duration DT, once the setpoint or setpoints C have been reached, and programming for an operating decision referred to as ‘forced mode’ during the regeneration in progress depending on the history of use and/or the context of use. | 08-04-2011 |
20120017975 | LAMINATED GLASS PANE AND USE THEREOF - A laminated glass pane is described including a) a substrate glass, b) at least one layer structure applied to the substrate glass, c) at least one polymer layer applied to the layer structure, d) a cover glass on the polymer layer, wherein the mean coefficient of thermal expansion of the substrate glass is at most 18×10 | 01-26-2012 |
20130312341 | ELECTROCHEMICAL GLAZING HAVING ELECTRICALLY CONTROLLABLE OPTICAL AND ENERGY-RELATED PROPERTIES - The invention relates to glazing ( | 11-28-2013 |
Annabelle Andreau-Wiedermaier, Aachen DE
Patent application number | Description | Published |
---|---|---|
20110132888 | DEVICE FOR ELECTRICALLY CONNECTING LAMINATED GLAZING TO AN APPARATUS OUTSIDE THE GLAZING, METHOD FOR ASSEMBLING GLAZING PROVIDED WITH ONE SUCH CONNECTION DEVICE, AND RESULTING GLAZING - A connection device configured to equip a laminated glazing unit requiring an electrical connection to equipment outside of the glazing unit. The laminated glazing unit includes at least one set of two sheets having a glass function between which are positioned a lamination interlayer sheet and at least one current lead. The connection device includes conductive portions that extend both on the inside and outside of the glazing unit, the internal conductive region configured to be connected to the current lead(s) and the external conductive region configured for connection to the equipment outside of the glazing unit and protected by an insulating shell. The external conductive region with its insulating shell is in a form of a connection box for connection via wiring to the equipment outside the glazing unit, the box including a mechanism receiving the conductive portion inside the glazing unit. | 06-09-2011 |
Annabelle Bouchardon, Lyon FR
Patent application number | Description | Published |
---|---|---|
20090155886 | NUCLEIC ACIDS AND POLYPEPTIDES SPECIFIC FOR PATHOGENIC STRAINS OF THE NEISSERIA GENUS - The invention concerns nucleic acids coding for polypeptides specific of the | 06-18-2009 |
20100184639 | NUCLEIC ACIDS AND POLYPEPTIDES SPECIFIC OF THE NEISSERIA GENUS PATHOGENIC STRAINS - The invention concerns nucleic acids coding for polypeptides specific of the | 07-22-2010 |
Annabelle Couvert, Rennes FR
Patent application number | Description | Published |
---|---|---|
20100166597 | Device for Treating a Gaseous Effluent Loaded with Odorant Compounds using a Three-Dimensional Mesh, Corresponding Installation and Process - The invention relates to a device for treating a gaseous effluent loaded with odorant compounds, comprising a reactor ( | 07-01-2010 |
Annabelle Eudeline-Ly, Lamorlaye FR
Patent application number | Description | Published |
---|---|---|
20150101132 | CATIONIC DYE BEARING AN ANIONIC ORGANIC COUNTERION, DYE COMPOSITION COMPRISING THEM AND PROCESS FOR DYEING KERATIN USING THESE DYES - The invention relates to the dyeing of human keratin fibres, especially the hair, using cationic direct dyes bearing a particular sulf(on)ate, carboxylate, or phosph(on)ate counterion of formula (I) in which formula (I) Col | 04-16-2015 |
Annabelle Gallois-Bernos, Jacksonville, FL US
Patent application number | Description | Published |
---|---|---|
20130005691 | ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS - The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a polyol wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens. | 01-03-2013 |
20130005805 | ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS - The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a monohydric alcohol or an amide wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens. | 01-03-2013 |
20140005514 | METHOD AND OPHTHALMIC DEVICE FOR GALVANIC HEALING OF AN EYE | 01-02-2014 |
20140364400 | ESTERS FOR TREATMENT OF OCULAR INFLAMMATORY CONDITIONS - The present invention relates to ophthalmic compositions and methods for the treatment of dry eye and other inflammatory ocular conditions. In particular, the present invention relates to a composition comprising an esterified anti-inflammatory lipid mediator, which is an ester of an anti-inflammatory lipid mediator that is a reaction product of the anti-inflammatory lipid mediator and a polyol wherein the majority of the anti-inflammatory lipid mediator is present in an ester form. In this way, the compositions are substantially free of an acid form of the anti-inflammatory lipid mediators. This composition can be topically delivered to the ocular surface via a preparation, solution, gel, ointment, and/or strip and/or a contact lens. | 12-11-2014 |
Annabelle Geze, Grenoble FR
Patent application number | Description | Published |
---|---|---|
20100093662 | NOVEL AMPHIPHILIC CYCLODEXTRIN DERIVATIVES - The present invention relates to cyclodextrins having the following formula (I): to nanostructures comprising them, to processes for preparing them, to the use thereof, and also to compositions comprising them. | 04-15-2010 |
Annabelle Grolleau-Julius, Ann Arbor, MI US
Patent application number | Description | Published |
---|---|---|
20110059054 | ENHANCED DENDRITIC CELLS FOR CANCER IMMUNOTHERAPY - Described herein are methods of cancer immunotherapy, particularly methods of preparing a population of enhanced dendritic cells and methods of treating cancer using the enhanced dendritic cells. | 03-10-2011 |
Annabelle Mantilleri, Apt FR
Patent application number | Description | Published |
---|---|---|
20160113996 | TAFA4 COMPOUNDS AND USES THEREOF FOR TREATING PAIN - The present invention relates to novel compounds for use for preventing, alleviating or treating pain in a subject. Also herein described are pharmaceutical compositions, their preparation and uses as well as methods for preventing, alleviating or treating pain using such compounds and compositions. | 04-28-2016 |
Annabelle Rodriguez, Farmington, CT US
Patent application number | Description | Published |
---|---|---|
20160074417 | SR-BI AS A PREDICTOR OF HUMAN FEMALE INFERTILITY AND RESPONSIVENESS TO TREATMENT - Methods of diagnosis and treatment of diseases and disorders related to de novo synthesis of cholesterol, based on allelic variants of the scavenger receptor class B type I receptor, and kits for use therein. | 03-17-2016 |
Annabelle Rodriguez Oquendo, Farmington, CT US
Patent application number | Description | Published |
---|---|---|
20130345187 | METHOD FOR PRE-SCREENING AND CORRELATION OF UNDERLYING SCARB1 GENE VARIATION TO INFERTILITY IN WOMEN AND THERAPEUTIC USE OF PROGESTATIONAL AND OTHER MEDICATIONS IN TREATMENT - A method of genotyping women experiencing infertility for non-physical reasons in order to identify the presence of the rs4238001 and/or rs10846744 mutation of the SCARB1 gene and, upon identifying the presence of one or both genetic mutations, administering a tailored therapeutic regimen to restore fertility by either one or a combination of 1) mediating the flux of cholesterol resulting from the mutation by therapeutic use of the cholesterol medication probucol and/or other cholesterol altering medications, and/or 2) amplifying the presence of hormone progesterone by therapeutic use of progestational and progestin medications. | 12-26-2013 |
20150355203 | USE OF LYMPHOCYTE ACTIVATION GENE 3 (LAG-3) EXPRESSION PROFILING AS A BIOMARKER FOR ASSESSING INFLAMMASOMES, CHRONIC INFLAMMATORY DISEASES AND DYSFUNCTIONAL HDL - A method for determining whether a subject has or is predisposed to abnormal expression of inflammasomes and/or to dysfunctional HDL suitable for use in diagnosing atherosclerosis, chronic inflammatory disease, Incident Cardiovascular Disease (ICD) and other pathologies characterized by an inflammatory response. Specifically, a protein assay that measures LAG-3 can be used as a diagnostic predictor of pathologies such as infection, inflammation, chronic inflammatory disease, and coronary artery disease. The diagnostic is combined with the therapeutic use of a remediating drug for treatment. | 12-10-2015 |
Annabelle Roy-Martinache, Pontoise FR
Patent application number | Description | Published |
---|---|---|
20100019124 | MOULD FOR THE INJECTION-MOULDING A COMPONENT COMPRISING TWO PORTIONS WHICH ARE COMPOSED OF DIFFERENT MATERIALS - This mould is of the type including a moulding cavity ( | 01-28-2010 |
Annabelle Schubert, Hilden DE
Patent application number | Description | Published |
---|---|---|
20150240320 | VIRUS PARTICLE STABILISATION AND METHOD FOR ISOLATING VIRAL NUCLEIC ACIDS - The present disclosure provides methods, compositions and devices for isolating virus particles and/or viral nucleic acids from body samples that were stabilized using a stabilizing composition comprising a formaldehyde releaser agent. | 08-27-2015 |
20150275268 | STABILISATION OF BIOLOGICAL SAMPLES - The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample and for stabilizing the transcriptome of contained cells. | 10-01-2015 |
Annabelle Servais-Dealet, Bry Sur Marne FR
Patent application number | Description | Published |
---|---|---|
20150182440 | COSMETIC COMPOSITION COMPRISING A HYDROCARBONATED-BASED RESIN, A HYDROCARBON-BASED BLOCK COPOLYMER, A NON VOLATILE DIMETHICONE OIL AND A NON VOLATILE HYDROCARBONATED OIL - The present invention relates to compositions for making up and/or caring for the skin and/or the lips, comprising at least one fatty phase comprising:—at least one hydrocarbon-based resin with a number-average molecular weight of less than or equal to 10 000 g/mol,—at least one hydrocarbon-based block polymer,—from 11% to 80% by weight of non volatile non phenylated silicone oil(s) having at least a dimethicone part, relative to the total weight of the composition, and—from 1% to 80% by total weight of non volatile hydrocarbonated apolar oil(s), relative to the total weight of the composition. | 07-02-2015 |
Annabelle Temml, Saltsjo-Boo SE
Patent application number | Description | Published |
---|---|---|
20100311000 | CANDLE HOLDER - The invention refers to a candle holder for fixing candles in a candlestick and comprising a sleeve ( | 12-09-2010 |